Vimarsana
Biggest News Aggregation in the World

David Lanfear News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Lanfear. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Lanfear Today - Breaking & Trending Today

Letters to the Editor (1/24/24) - Vimarsana News

Letters to the Editor (1/24/24)

'Carpetbagger' Candidate [Re "Former Middlebury Selectboard Member Announces Bid for Governor," January 5, online]: A 33-year-old from Connecticut running for governor of Vermont? Are you...

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients - Vimarsana News

Illumina and Henry Ford Health team up to study impact of comprehensive genomic testing for cardiovascular patients

/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Henry Ford Health, a not-for-profit health...

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease - Vimarsana News

Study to measure the impact of whole genome sequencing in patients with cardiovascular disease

Henry Ford Health research teams are launching a series of clinical studies in partnership with Illumina Inc., a global leader in DNA sequencing and array-based technologies, to assess the impact of comprehensive genomic testing in various disease areas.

Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients - Vimarsana News

Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular Patients

The partnership could yield data to support the use of whole-genome sequencing in treating and managing cardiovascular disease, the leading cause of death in the US.

V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure - Vimarsana News

V-Wave Completes Enrollment in the RELIEVE-HF Randomized Double-Blind Controlled Trial of Interatrial Shunting for Heart Failure

The RELIEVE-HF trial of the Ventura Shunt System includes patients with reduced and preserved left ventricular function etiologies for heart failure